Article thumbnail

MRC chronic Dyspnea Scale: Relationships with cardiopulmonary exercise testing and 6-minute walk test in idiopathic pulmonary fibrosis patients: a prospective study

By Effrosyni D Manali, Panagiotis Lyberopoulos, Christina Triantafillidou, Likourgos F Kolilekas, Christina Sotiropoulou, Joseph Milic-Emili, Charis Roussos and Spyros A Papiris
Topics: Research article
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:2893122
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (1987). A: Determination of aerobic capacity and the severity of chronic cardiac and respiratory failure. Circulation
  2. (2006). AF: The distance-saturation product predicts mortality in idiopathic pulmonary fibrosis. Respir Med
  3. (2000). American Thoracic Society, European Respiratory Society, American College of Chest Physicians: Idiopathic Pulmonary Fibrosis, diagnosis and treatment. International Consensus statement. Am J Respir Crit Care Med
  4. (2002). American Thoracic Society; European Thoracic Society: Idiopathic interstitial pneumonias.
  5. (2007). Arizono S: Dyspnoea at 6 minute walk test in idiopathic pulmonary fibrosis: comparison with COPD. Respir Med
  6. (2003). ATS/ACCP Statement of cardiopulmonary testing.
  7. (2008). AW: The association between idiopathic pulmonary fibrosis and vascular disease. A population-based study. Am J Respir Crit Care Med
  8. (2007). BJ: Recommendations on the use of exercise testing in clinical practice. Eur Respir J
  9. (2005). Bouros D: Evaluation of health-related quality of life and dyspnea scales in patients with idiopathic pulmonary fibrosis. Correlation with pulmonary function tests.
  10. (2008). Bouros D: Left ventricular diastolic dysfunction in idiopathic pulmonary fibrosis: a tissue Doppler echocardiographic study. Eur Respir J
  11. (2005). C: The MRC scale in the estimation of disease severity in IPF. Respir Med
  12. (1994). CG: Dead space loading and exercise limitation in patients with interstitial lung disease. Chest
  13. (1997). Coasts AJ: Clinical correlates and prognostic significance of the ventilatory response to exercise in chronic heart failure.
  14. (1987). Daubenspeck JA: Comparison of clinical dyspnea ratings and psychophysical measurements of respiratory sensation in obstructive airway disease. Am Rev Respir Dis
  15. (1996). Determinants of maximal oxygen transport and utilization. Ann Rev Physiol
  16. (1992). EJM: Exercise capacity and ventilatory, circulatory and symptom limitation in patients with chronic airflow limitation. Am Rev Respir Dis
  17. (2005). Exercise testing determines survival in patients with diffuse parenchymal lung disease evaluated for lung transplantation. Respir Med
  18. (2003). F: Prognostic value of desaturation during a 6MWT in Idiopathic pulmonary fibrosis. Am J Respir Crit Care Med
  19. (2006). FJ: Idiopathic pulmonary fibrosis: prognostic value of changes in physiology and six-minute walk test. Am J Respir Crit Care Med
  20. (2009). Flaherty KR: The prognostic value of cardiopulmonary exercise testing in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med
  21. (2006). Functional predictors of exertional dyspnea, 6 min walking distance and HRCT fibrosis score in idiopathic pulmonary fibrosis. Respiration
  22. (1984). Gaensler EA: Exercise alveolar-arterial oxygen pressure difference in interstitial lung disease. Chest
  23. (2002). Guidelines for the 6 minute walk test.
  24. (2008). Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society. Thorax
  25. (2006). Kawut SM: Sixminute walk distance predicts waiting list survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med
  26. (2002). Kotloff RM: Usual interstitial pneumonia. Histologic study of biopsy and explant specimens.
  27. (2002). Lovetro Galhardo FP, de Castro Pereira CA: Dyspnea scales as a measure of health-related quality of life in patients with idiopathic pulmonary fibrosis. Med Sci Monit
  28. (1993). Lung volumes and forced ventilatory flows. Report working party, Standardization of lung function tests,
  29. (2009). Mechanisms of activity related dyspnea in pulmonary diseases. Respir Physiol Neurobiol
  30. (2003). Ogura T: Impairments and prognostic factors for survival in patients with idiopathic pulmonary fibrosis. Respir Med
  31. (2005). Papiris S: CD8+ T lymphocytes in lung tissue from patients with idiopathic pulmonary fibrosis. Res Res
  32. (2008). Papiris SA: Medical Research Council chronic dyspnea score predicts the survival of patients with idiopathic pulmonary fibrosis. Respir Med
  33. (1996). Pathophysiology of activity limitation in patients with interstitial lung disease. Chest
  34. (1996). Peripheral muscle weakness contributes to exercise limitation in COPD.
  35. (2001). Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model.
  36. (1986). Pulmonary vascular responsiveness at rest and during exercise in idiopathic pulmonary fibrosis: effects of oxygen and nifedipine. Respiration
  37. (2005). Raghu G: The time walked test as a measure of severity and survival in idiopathic pulmonary fibrosis. Eur Respir J
  38. (1991). Rodringuez-Roisin R: Mechanisms of gas exchange impairment in idiopathic pulmonary fibrosis. Am Rev Respir Dis
  39. (2005). Scano G: Dyspnea and leg effort during exercise. Res Med
  40. (2009). Sch├Ąper C: Impact of pulmonary hypertension on gas exchange and exercise capacity in patients with pulmonary fibrosis. Res Med
  41. (2005). Six minute walk, maximal exercise tests: reproducibility in fibrotic interstitial pneumonia. Am J Respir Crit Care Med
  42. (1992). Ventilation-perfusion matching during exercise. Chest
  43. (2007). Z: CD8+ lymphocytes in bronchoalveolar lavage in idiopathic pulmonary fibrosis. J Inflamm (Lond)